New approach to multiply deuterated isoprenoids using triply engineered Escherichia coli and its potential as a tool for mechanistic enzymology
New approach to multiply deuterated isoprenoids using triply engineered Escherichia coli and its potential as a tool for mechanistic enzymology
复制标题
DOI:
10.1021/ja003390y
复制
发表时间:
2001-02-14
影响因子:
15
通讯作者:
Seto, H
中科院分区:
文献类型:
--
作者:
Kakinuma, K;Dekishima, Y;Seto, H
Isoprenoids are chemically diverse in nature, ubiquitous in living organisms, and crucial in biological processes. The biosynthesis of such isoprenoids proceeds through mevalonate1 and non-mevalonate pathways2 depending upon organisms and cellular organella, isopentenyl diphosphate (IPP) being a key intermediate in both cases. Metabolic engineering and control of these pathways should thus provide new opportunities to study the intriguing chemistry and biochemistry involved and to develop selective chemotherapeutic agents and isoprenoid-related materials. This paper describes a new practical approach for the preparation of highly deuterated isoprenoids, such as zeaxanthin, and their potential for analyzing the biosynthetic mechanism of isoprenoids, based on the metabolic engineering of Escherichia coli. Deuteriumlabeled compounds are invaluable in biochemical and bioorganic as well as physicochemical research. The non-mevalonate pathway, but not the mevalonate pathway, is now known to function in E. coli. Recently, Seto et al. 3, 4 and Boronat et al. 5 described the construction of doubly engineered E. coli with the disruption of a gene of a certain enzyme involved in the non-mevalonate pathway and the introduction of the genes responsible for the key enzymes in the mevalonate pathway. These sort of transformant cells can survive only with supplementation of metabolic intermediates in the mevalonate pathway. Importantly, this warrants that all of the IPP formed in the cells must be derived from the supplemented intermediate. E. coli DK2236 (pTMV20, 7 pACCAR25ΔcrtX) was constructed in this manner, but was actually triply engineered. That is, the 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) gene was disrupted, and a plasmid pTMV20 carrying the genes of three enzymes responsible for the formation of IPP was introduced. In addition, another plasmid pACCAR25ΔcrtX was introduced, which carried the crtE, crtB, crtI, crtY, and crtZ genes required for the synthesis of zeaxanthin. 8 This strain survived and produced a yellow pigment of zeaxanthin in the presence of exogenous mevalonate. 9 Fully deuterated mevalonolactone-d9 (MVL-d9), which had been synthesized as described previously, 10 was supplemented to the culture of the above triply engineered E. coli. 11 The biosynthesized zeaxanthin was extracted and purified to homogeneity by repeated chromatography. The molecular ion (M+) of the purified product was observed as a cluster of isotopomer ions between m/z 605-622. No trace of an ion at m/z 568 (nonlabeled M+) was detected. All of the zeaxanthin formed was proved to be derived only from the supplemented MVL-d9. This was the first example of such highly and multiply deuterated zeaxanthin and clearly demonstrates the significant potential of the present approach for the preparation of various isotope-labeled isoprenoids.As to the biosynthetic mechanism, the fact that zeaxanthin was biosynthesized in the above engineered E. coli appears to suggest that the whole mevalonate pathway including IPP isomerase was viable. 12 In addition, the clustered M+ ion clearly implies variable deuterium content from molecule to molecule. This appears to be due to the exchange of hydrogen at the methyl group of intermediary dimethylallyl diphosphate (DMAPP) during the isomerase reaction and accordingly at the C-4 methylene group of IPP as well. Thus, once a proton is incorporated into the freely rotating C-4 methyl group of DMAPP, the reverse reaction from DMAPP to IPP should afford (E)-and (Z)-protonated IPP equally as shown in Figure 1.